University of Thessaly (UTH)
Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα
Abstract
dc:descriptionMultiple Myeloma (MΜ) is a B-cell neoplasia characterized by the malignant proliferation of plasma cells in the bone marrow. The malignant plasma cells produce a monoclonal immunoglobulin (M-protein or paraprotein) and cause bone marrow infiltration, osteolysis, anemia, renal impairment and susceptibility to microbial infections. The disease, whose incidence is estimated at 1-2 cases per 100,000 people, mainly affects the elderly and is responsible for 1% of deaths caused by tumors. The prognosis and clinical course varies among patients with MM; survival time may vary from several days to over 10 years. Epidemiological studies have shown that the MM in one third of patients results from pre-existing benign monoclonal gammopathy while in the other two thirds it is presented by skipping underlying conditions and often with an aggressive progression. Therefore, MM could be classified into two types, primary and secondary. This biological and clinical heterogeneity of the disease implies the involvement of complex genetic mechanisms that determine the pathogenesis and progression through different pathways. The understanding of these genetic modifications is crucial for prognosis, clinical monitoring and treatment of patients with MM.Cytogenetic study appears to contribute to the prognosis and course of disease progression by revealing chromosomal disorders in 20-30% of patients with MM. The application of molecular cytogenetics (fluorescent in situ hybridization, FISH) in interphase nuclei has contributed to the detection of abnormalities in about 60% of patients. Some abnormalities appear to be typical of the disease and associated with prognosis. The most common chromosomal abnormalities involve deletions of chromosomes 13 [del (13q)] and 11 [del (11q)], translocations t (4; 14), t (11; 14), t (14; 16), polyploidies, hyperdiploidies, hypodiploidies, pseudodiploidies and paratetraploidies.Very recently, it was found that Copy Number Variations (CNVs) of the human genome are a new source of information concerning the structure of chromosomes. CNVs may result from gain, deletion or doubling of chromosomal regions, varying in size from a few kilobases (Kb) to several megabases (Mb) and may affect the gene copy number resulting in a change in protein synthesis (gene dosage), abolish gene function, change genes’ structure, or deregulate gene expression. Based on the above, CNVs may be a cause of phenotypic diversity in both physiological and pathological conditions.In MM, the continuous study of CNVs under normal and pathological conditions, is expected to decipher the mechanisms that play an important role in the phenotypic diversity of people and different susceptibility among individuals to the disease development.Moreover, other studies have focused on growth factors such as cytokines of MM. Cytokines are proteins or glycoproteins that regulate communication between immune and non-immune cells and exert functional effects on proliferation, motility, differentiation and function of target cells involved in the immune system. Cytokines are produced by various cells in response to antigen or inflammatory stimulation in an autocrine, paracrine and rarely endocrine manner.The need to understand the causes and pathological bases of cancer have led the effort of finding genetic mutations that may play an important role in genetic predisposition, emergence and progression of the disease. Research has been directed towards finding genes of low penetration, frequently occuring in the genome, and which are involved in the predisposition to cancer in a significant number of patients. In recent years, research has been focused on the investigation of gene polymorphisms of cytokines, particularly within the genes’ promoter regions, which could affect gene transcription to varying degrees. Polymorphisms are common inherited variants of the DNA sequence, exhibiting a frequency greater than 1% in the general population. Several types of polymorphisms are found within the human genome, such as single nucleotide polymorphisms (SNPs), single-base deletions and duplications. The frequency of polymorphic alleles may vary between populations as well as within the same population.The purpose of the present thesis is:•to study of the frequency of chromosomal abnormalities in patients with MM and to correlate with survival.•to study nonrandom chromosomal abnormalities in patients with MM using fluorescent in situ hybridization (FISH)•to investigate copy number variations (CNVs) of the genome in patients with MM, both with normal and abnormal karyotype .•to compare the results of the above three techniques with respect to the sensitivity of detection of genetic abnormalities.•To explore single nucleotide polymorphisms of the genes of cytokines IL-1A, IL-1B, IL-1RN in patients with MM for the assessment of their participation as predisposing factors .The study is divided into two parts: The first part presents data concerning the occurrence and pathogenesis of multiple myeloma, the cytogenetic and genetic mechanisms involved in cancer and specifically in MM, as well as the diagnosis, staging and prognosis of the disease. Finally, the role of cytokines and polymorphisms in their genes in the immune response against neoplasias will be analyzed.The second part describes the following:The study groups: the study included 77 samples MM patients. The collection and characterization of the samples of the study was performed in the Clinic of Hematology of the General Hospital of Larissa.The cytogenetic analysis of MM samples, upon cell culture.The molecular cytogenetic analysis of MM samples by fluorescent in situ hybridization in interphase nuclei. The molecular analysis of the MM samples with the technique of comparative genomic hybridization (array CGH).The molecular analysis of gene polymorphisms of interleukin-1, interleukin-1 receptor and antagonist and the study of their frequency in the normal population and in patients with MM.The statistical correlation of cytogenetic findings with conventional karyotyping and FISH with MM patient survival. The time of survival was defined as the 24-month survival upon diagnosis.In the present study two major aneuploid groups were identified: the hyperploid group (47 to 75 chromosomes), and the non-hyperploid group (30-45 chromosomes) including pseudodiploidies (46 chromosomes) and hypotetraploidies (75-90 chromosomes) and patients with a repeating structural abnormality associated with MM such as partial deletion of chromosome 13 or translocations t (4;14) and t (11;14). The molecular cytogenetic analysis by FISH (fluorescent in situ hybridization) for the 13q14 deletion, the t(4;14), t(11;14) and t(14;16) translocations and the 14q32rearrangements with other chromosomes, led to the identification of these abnormalities both in patients with MM and visible chromosomal abnormalities, as well as in patients with normal karyotype. The statistical analysis of the findings demonstrated a statistically significant difference in the survival of patients with an abnormal karyotype compared to patients with a normal karyotype. Survival rates were found to be significantly reduced in patients bearing the del(13q14), particularly in combination with an abnormal karyotype, while 14q32 rearrangements and especially t(4;14) translocation, were found to drastically affect the survival of patients, especially in combination with hyperdiploidy.Three samples from patients with MM (one with a normal karyotype, one with an abnormal karyotype and a finding in FISH and one with a normal karyotype and finding in FISH), were analyzed using the method of Comparative Genomic Hybridization (array CGH) and confirmed the above defects and detected additional structural abnormalities involving duplications and deficiencies, which were not detected by conventional karyotyping.Finally, the study of distribution of cytokine polymorphisms in 74 Greek MM patients and 160 normal controls, revealed a correlation between the frequency of single nucleotide polymorphisms in interleukins IL-1A (position -889 C/T), IL-1B (positions -511 C/T, + 3954 C/T), IL-1RN (position pst +11970 C/T and position msp 1 +11100 C/T) and MM.In conclusion, the present study suggests that the technique of conventional cytogenetics is sufficiently effective to detect a malignant clone in MM patients of stages II and III. The cytogenetic analysis of samples demonstrated that the non-hyperdiploid group predominates numerically the hyperdiploid group (3:1), shows structural chromosomal abnormalities at a much greater rate and is accompanied by lower survival rates. The study revealed a repeated non-accidental total or partial loss of chromosome 13 in a large proportion of patients, leading to the conclusion that it constitutes an early genetic event in the pathogenesis and progression of MM. The further application of the FISH technique increased the sensitivity and specificity of detection of abnormal clones and led to a doubling in the number of patients with findings. Moreover, the application of FISH led to the conclusion that the del(13q14) is a strong independent prognostic parameter, while the translocation t(4;14) also pointed out as bad predictor. Briefly, upon logistic regression analysis, patients with chromosomal abnormalities exhibited 10 times greater risk not to survive during the study period, 5 times in patients with del(13q14) and 3 times patients with 14q32 rearrangements. The application of array-CGH with high resolution microarrays in 3 patient samples revealed molecular rearrangements in regions containing substantially important oncogenes or tumor suppressor genes, which were not detected with the techniques of conventional karyotyping and FISH, leading to the conclusion that the array-CGH could serve as a diagnostic tool for the control of the entire genome. Finally, the study of gene polymorphisms of cytokines revealed that the genotypes IL-1A -889 CT, IL-1B -511 CT, IL-1B +3954 TT, IL-1RN +11970 TT and IL-1RN +11100 TT revealed an association of these with the MM in Greek patients, suggesting the possible involvement of the proinflammatory cytokine IL-1 in the predisposition of MM.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stampoulia-Stampoulieh, Danai
- Σταμπούλια-Σταμπούλη, Δανάη
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34904